Efficacy and safety of acupuncture for acute renal colic caused by urinary calculi: a randomized controlled trial.

Phase 1

• Conditions: acute renal colic caused by urinary calculi

• Registration Number: ITMCTR1900002529
• Lead Sponsor: Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Diagnosed according to European Association of Urology guideline (2017).
2. Aged 18–75 years (either sex).
3. Patients with moderate to severe renal colic (Visual Analogue Scale, VAS>=4).
4. Written informed consent.

Exclusion Criteria

1. Use of any analgesia in last 6 hours.
2. Allergic to diclofenac, morphine, or anisodamine; history of asthma, urticaria or allergic rhinitis induced by taking acetylsalicylic acid or other drugs containing prostaglandin synthase inhibitors.
3. Congestive heart failure, acute ischemic heart disease, or peripheral vascular disease.
4. Acute cerebrovascular disease, increased intracranial pressure.
5. Renal or liver failure.
6. Active digestive ulcer, pyloric obstruction, or intestinal obstruction.
7. Blood system diseases: such as hemophilia, coagulation disorders in patients; Thrombocytopenia (< 50x10^9/L); Using anticoagulants.
8. Glaucoma, elevated intraocular pressure.
9. People who have had serious adverse reactions to acupuncture.
10. Acupuncture site of skin infection.
11. Have a history of mental illness or substance abuse, or have severe cognitive impairment.
12. Pregnant or lactating.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Response rate (the proportion of participants whose pain reduced >= 50% compared with baseline);

Secondary Outcome Measures

Name	Time	Method
Visual Analogue Scale;Re-visit rate and admission rate;The rate of patients requiring additional pain relief;Response rate (the proportion of participants whose pain reduced >=50% compared with baseline);Adverse events;